Epleronone Shown To Reduce Atrial Fibrillation
Links shared publicly online about this topic.
- 272total visits
Epleronone Shown To Reduce Atrial Fibrillation
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, Arrhythmia, Atrial Fibrillation, Heart Failure, Pfizer
Most Recently Shared on May 23, 2011 at 9:57 am By:
Epleronone Shown To Reduce Atrial Fibrillation: The aldosterone antagonist eplerenone (Inspra, Pfizer) significa... http://bit.ly/lSOiwQ
Epleronone Shown To Reduce Atrial Fibrillation
medicalnewstoday.com — “The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 8:05 am By:
MNT Cardiovascular Health News
Epleronone Shown To Reduce Atrial Fibrillation http://mnt.to/3WbK #cardiovascular
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
medicalxpress.com — “The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart ...” View full resource at medicalxpress.com
Most Recently Shared on May 22, 2011 at 4:59 pm By:
PhysOrg Health News Health News
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation http://tw.medicalxpress.com/225287940
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
eurekalert.org — “The aldosterone antagonist eplerenone significantly reduced the development of new onset atrial fibrillation and flutter in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology.” View full resource at eurekalert.org
Most Recently Shared on May 22, 2011 at 3:55 pm By:
Tammi Jacobs Health Professional
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation http://bit.ly/lThVxt
Dabigatran Etexilate Shows Greater Reductions Than Warfarin in Stroke in Patients with Atrial Fibrillation across All Stroke Risk Groups | EON: Enhanced Online News
feeds.businesswire.com — “INGELHEIM, Germany--(EON: Enhanced Online News)--Data presented today at the 59th Annual Scientific Session of the American College of Cardiology have shown greater reductions in stroke in patients with atrial fibrillation (AF) for dabigatran etexilate* compared to the current standard of care, warfarin, irrespective of a patient’s risk profile for stroke.1 The new sub-group analysis from the landmark RE-LY® study** assessed the rate of stroke and systemic embolism in patients defined ” View full resource at feeds.businesswire.com
Most Recently Shared on March 15, 2010 at 4:10 pm By:
Dabigatran (Coumadin-repl) reduces strokes more than warfarin in atrial fibrillation patients: http://bit.ly/be8sd1 @EON_Health #ACC10 #afib
Omega-3 Fatty Acids Prevent Atrial Fibrillation | The Heart Health Blog From NutritionData.com
blog.nutritiondata.com — “Atrial fibrillation, the most common complication of heart bypass operations, was shown in an Italian study to be reduced by half in patients who took an omega-3 fatty acid supplement.” View full resource at blog.nutritiondata.com
Most Recently Shared on June 11, 2009 at 3:50 pm By:
Omega-3 Fatty Acids Prevent Atrial Fibrillation http://ff.im/-3R4u8
Ablation strategies for AF
theheart.org — “An ablation strategy that combines pulmonary vein isolation with substrate-based ablation works best for eliminating atrial fibrillation at one year when compared with ablation techniques targeting only the pulmonary veins or substrate, a new study has shown.” View full resource at theheart.org
Most Recently Shared on May 15, 2009 at 3:54 pm By:
heartwire: Pulmonary vein isolation plus substrate ablation best for reducing AF http://bit.ly/bk6rq
Advertisement
